Sabatini Brent 4

What Happened

• Brent Sabatini, SVP and Chief Accounting Officer of Vir Biotechnology, sold 1,430 shares on 2026-02-24 at $9.53 per share, generating gross proceeds of approximately $13,632. The sale is reported as a disposition (transaction code S) and was executed automatically to satisfy tax-withholding obligations tied to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date and price: 2026-02-24 at $9.53 per share.
• Shares sold: 1,430; gross proceeds ≈ $13,632.
• Footnote: Sale was automatic under a Rule 10b5-1 arrangement to cover tax withholding for RSU vesting (not a discretionary trade).
• Filing date: 2026-02-26 (filed two days after the transaction; appears to be within the typical Form 4 reporting window).
• Shares owned after transaction: Not specified in the provided summary—see the official Form 4 for post-transaction ownership details.

Context

• Sales made solely to cover tax obligations on vested RSUs are routine and generally do not signal a change in insider sentiment. Purchases tend to be more informative about insider confidence than automated withholding sales. For full details, consult the filed Form 4 (Accession 0001628280-26-012396).